Cargando…
CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1
PURPOSE: Recent studies indicate that CXC chemokine receptor type 7 (CXCR7) is associated with tumorigenesis, progression, and metastasis of various cancers, but its roles and molecular mechanisms of action in cervical squamous cell carcinoma (CSCC) remain unclear. Our purpose was to explore the exp...
Autores principales: | Zhao, Danyang, Qin, Wenban, Zhao, Chuanxiang, Long, Jianxiong, Li, Mujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910105/ https://www.ncbi.nlm.nih.gov/pubmed/31849518 http://dx.doi.org/10.2147/CMAR.S228684 |
Ejemplares similares
-
Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?
por: Wang, Yaxian, et al.
Publicado: (2016) -
Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
por: Zhang, Weifeng, et al.
Publicado: (2019) -
Clinical analysis of 312 patients with stage IB1-IIA2 cervical squamous cell carcinoma and research on the influencing factors of postoperative recurrence
por: Zeng, Jia, et al.
Publicado: (2023) -
MRI outcome evaluation in patients with IB2 and IIA2 squamous cervical cancer stages: preliminary results
por: Song, Qingling, et al.
Publicado: (2022) -
Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer
por: Zhou, Juan, et al.
Publicado: (2015)